Finally, miR-125a suppresses metastasis and cisplatin resistance in several types of cancer through repression of c-Myc, matrix metalloproteinase (MMP)-2, and MMP-9 by directly inhibiting STAT3 expression [210,211]. This evidence concerns the gene MYC and cancer.